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TGN38/41 is an integral membrane protein which recycles between the trans-Golgi network tJGN) and the cell surface but is predominantly located 
in the TGN of rat (NRK) cells at steady state. As part of our studies on the mechanism and route of recycling between the TGN and the cell surface 
we have used chloroquine or Batilomycin A, to modulate the lumenal pH of endocytic organelles. The data we present demonstrate that inactivation 
of the proton pump which maintains the acidic environment within the lumen of endocytic organelles leads to an accumulation of TGN38/41 in early 
endosomes. These data confirm the observation that TGN38/41 recycles between the plasma membrane and the TGN and identifies a specific block 
in that recycling pathway. 
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1. Introduction 
The classical secretory pathway in higher eukaryotic 
cells involves the passage of newly synthesised proteins 
through a discrete set of intracellular compartments be- 
fore sorting and targeting to the appropriate destination. 
An organelle which plays a major role in the latter stages 
of this process has been termed the truns-Golgi network 
(TGN)[l], and has been shown to be an organelle inde- 
pendent of the Golgi stack [2-4]. The TGN also plays a 
role in the endocytic pathway, since certain receptors 
recycle between it and the cell surface [5]. TGN38 and 
TGN41 are isoforms of an integral membrane protein 
predominantly localised to the TGN of normal rat kid- 
ney (NRK) cells [6,7’J which constitutively recycles be- 
tween the cell surface and the TGN [&lo]. The cytoplas- 
mic domain of TGN38/41 forms a complex with one or 
more low molecular weight G proteins and a cytosolic 
protein designated p62 [ll]. This interaction has been 
shown to be required for the formation of TGN derived 
vesicles [l l] and TGN38/41 has been postulated to play 
a role in transporting proteins from the TGN to the cell 
surface [12]. A tetrapeptide motif (YQRL) in the cyto- 
plasmic domain of TGN38/41 has been shown to be 
required for its intemalisation from the plasma mem- 
brane and its return to the TGN [8,13,14]. A further 
region, within the transmembrane domain of TGN38/41, 
has recently been identified as a signal for retention of 
the molecule within the TGN [l&16]. Thus, the mecha- 
nisms and signals involved in membrane traffic pathways 
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between the cell surface and the TGN are gradually 
being unravelled. This process of elucidation would be 
further aided by the identification of points along the 
TGN/cell surface recycling pathway at which membrane 
traffic could be blocked. Lazarovits and Roth [17] have 
previously shown that pre-treatment of cells with chloro- 
quine blocks the recycling of a mutant haemaglutinin 
(HA) molecule (lyr-543) which bears a tyrosine contain- 
ing intemalisation motif. They suggest that Tyr-543 ac- 
cumulates within an endocytic compartment in chloro- 
quine treated cells. With this in mind, we chose to treat 
NRK cells with a variety of agents, specifically those 
which would disrupt the lumenal pH of organelles along 
the endocytic pathway, and then assay those cells for the 
steady state distribution of TGN38/41. We have found 
that elevation of the lumenal pH of organelles along the 
endocytic pathway leads to an accumulation of TGN381 
41 in an early endocytic compartment, prior to associa- 
tion of endosomes with the microtubule network. 
2. Materials and methods 
2. I. Reagents 
Cell culture media (DMEM), foetal calf serum and antibiotics were 
purchased from Gibco Life Technologies, Inc. (Paisley, Scotland). 
Chloroquine was purchased from Sigma, made up as a 100 mM stock 
solution in dH,O and used at the final concentrations indicated in the 
text and figure legends. Bafilomycin A, was purchased from Prof. K. 
Altendorf (University of Osnabruck, Germany), prepared as a stock 
solution at 10 mM in DMSO, stored at -2O’C and used at the final 
concentrations indicated in the text and figure legends. Brefeldin A was 
purchased from Epicentre Technologies (Madison, WI) through Cam- 
bio (Cambridge, UK) and used as previously described [4]. Nocodazole 
was obtained from Sigma Chemical Company (Poole, Dorset, UK). 
The concentration of nocodaxole was 20 mg/ml in all incubations and 
was kept as a 10 mg/ml stock in DMSO at -2O’C. NRK cells were 
cultured and processed for immunofluorescence microscopy as previ- 
ously described [4, IO]. 
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2.2. Antibodies 
The rabbit anti-rat TGN38/41 polyclonal antiserum used has been 
previously described [6,18]. The monoclonal anti-TGN38/41 antibody 
was raised to the 13 amino-terminal amino acids of TGN38 and is 
described elsewhere [19]. The anti-lgp120 monoclonal antibody was 
generously provided by Dr. Paul Luzio (University of Cambridge, 
Cambridge, UK), the anti-mannosidase II monoclonal antibody [20,21] 
by Dr. Graham Warren (ICRF, London) and the anti-mannose-6- 
phosphate receptor antibody by Dr. Suzanne Pfeffer (Dept. of Bio- 
chemistry, Stanford University Medical Center, Stanford, USA). 
FITC- and TRITC-labelled goat anti-mouse and goat anti-rabbit anti- 
bodies were purchased from Sigma Chemical Co. (Poole, Dorset, UK). 
3. Results and discussion 
3.1. Chloroquine causes a redistribution of intracellular 
TGN38l41 
We initially chose to ask whether incubation of NRK 
cells in the presence of chloroquine would affect the in- 
tracellular distribution of TGN38/41. Chloroquine is a 
weak base which has previously been shown to inhibit 
the functional activity of Golgi enzymes [22] whilst hav- 
Fig. 1. Effects of chloroquine and Ba6lomycin A, on the intracellular distribution of TGN38/41 and mannosidam II. NRK cells were incubated in 
2 (A and B), 40 (C and D), or 200 PM (E and F) chloroquine or 5 pM Bafilomycin A, (G) for one hour at 37°C prior to methanol I fixation and 
proc essing for dual label immunofluorescence analysis using a polyclonal antibody to TGN38/41, detected with a TRITC-labelled go; at anti-rabbit 
IgG (A, C, E and G) and a monoclonal antibody to mannosidase II, detected with a FITC-labelled goat anti-mouse IgG (B, D and F). 
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Fig. 2. Time course of the effects of chloroquine treatment on the distribution of TGN3W41. NRK cells were incubated in 40 PM chloroquine for 
0 (A), 15 (B), 60 (Q, or 120 min (D) at 37°C urior to methanol fixation and processing for immunofluorescence analysis using a polyclonal antibody _- . ,- . ,. 
to TGN38/41 detected with a Tlk’k-labell& goat anti-rabbit IgG. 
ing little if any effect on the gross morphology of that 
organelle [23]. NRK cells were therefore incubated in the 
presence of increasing concentrations of chloroquine for 
one hour at 37°C prior to processing for double label 
immunofluorescence analysis (see section 2) using a pol- 
yclonal antibody to TGN38141 and a monoclonal anti- 
body to marmosidase II (an integral membrane protein 
of the cis, medial Golgi stacks [20,21]). The anti-TGN38/ 
41 pattern of staining clearly changed with increasing 
chloroquine concentration whilst that of anti-mannosi- 
dase II remained unaltered. (Fig. 1). Therefore chloro- 
quine affects the intracellular distribution of a TGN 
marker but not that of a resident membrane protein of 
the Golgi stack. 
Chloroquine is a lysosomotrophic amine which in- 
creases the lumenal pH of acidic organelles causing them 
to swell; its effects are therefore rather non-specific. In 
contrast, the macrolide antibiotic Bafilomycin A, has 
been shown to be a potent and specific inhibitor of vac- 
uolar H’-ATPases [24]. NRK cells were therefore incu- 
bated for one hour at 37°C in the presence of 5 PM 
Batilomycin A, prior to processing for immunofluores- 
cence analysis using a polyclonal antibody to TGN38/41 
(Fig. 1G). The intracellular distribution of TGN38/41 
observed after Bafilomycin A, treatment is similar to 
that observed after chloroquine treatment (compare Fig. 
1E and 1G). Batllomycin Ai had no effect on the intracel- 
lular distribution of mannosidase II (data not shown). 
Therefore Ba6lomycin A,, like chloroquine, affects the 
intracellular distribution of a TGN marker but not that 
of a resident membrane protein of the Golgi stack. 
A time course experiment demonstrates that the initial 
effects of chloroquine upon the intracellular localisation 
of TGN38/41 can be observed within 15 min of drug 
treatment (Fig. 2B) although one to two hours incuba- 
tion in the presence of chloroquine are required for the 
full morphological change to become apparent (Fig. 2C 
and 2D). 
3.2. Are the effects of chloroquine and Bajilomycin A, 
spec$c to the TGN? 
TGN38/41 is known to recycle between the TGN and 
the plasma membrane, so are the effects of chloroquine 
and Bafilomycin A, directly upon the TGN or do they 
al&t the morphology of endocytic compartments en 
route to the TGN? The mannose-6-phosphate receptor 
(M-6-PR) is known to be internalised from the plasma 
membrane and routed to an intracellular, M-6-PR rich, 
compartment [25,26]. In contrast, the majority of newly 
synthesised lysosomal integral membrane protein lgp120 
is targeted directly to lysosomal membranes from the 
TGN rather than going via the plasma membrane 
[27,28]. Thus, both pass through the TGN en route to 
their final destination, but only the M-6-PR travels via 
the plasma membrane. We therefore decided to look at 
the effects of chloroquine on the intracellular distribu- 
tion of M-6-PR and lgp120 in NRK cells. NRK cells 
were incubated in the absence (Fig. 3A-D) or presence 
(Fig. 3E-H) of 40 ,uM chloroquine for two hours at 37°C 
prior to processing for double label immunofluorescence 
analysis using a monoclonal antibody to TGN38/41 
(Fig. 3A and E) and a polyclonal antibody to M-6-PR 
(Fig. 3B and F) or a polyclonal antibody to TGN38 
(Fig. 3C and G) and a monoclonal antibody to lgp120 
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Fig. 3. Effects of chlor&ptine on the intracellular distribution of M-6-PR and lgp120. NRK cells were incubated in the absence (A-D) or presence 
(EH) of 40 PM chloroquine for two hours at 37°C prior to processing for dual label immunofluorescence analysis using a monoclonal antibody 
to TGN38/41 detected with a FITC-labelled goat anti-mouse IgG (A and E) and a polyclonal antibody to M-6-PR detected with a TRITC-labelled 
goat anti-rabbit IgG (B and F); or a polyclonal antibody to TGN38/41 detected with a TRITC-labelled goat anti-rabbit IgG (C and G) and a 
monoclonal antibody to lgp120 detected with a FITC-labelled goat anti-mouse IgG (D and H). 
(Fig. 3D and H). Chloroquine has a similar effect on the 
distribution of both the M-6-PR and TGN38/41, both 
appear to accumulate in the same ‘doughnut-like’ com- 
partments (compare Fig. 3E and 3F). However, although 
the lgp120 pattern of staining is affected by chloroquine 
pre- treatment (presumably due to swelling of lysosomes) 
(compare Fig. 3D and 3H) there is little, if any, colocal- 
isation of TGN38/41 and lgp120 in chloroquine treated 
cells (compare Fig. 3G and 3H). Similar results were 
obtained with Bafilomycin A,. 
Thus the morphological effects of perturbants of the 
lumenal pH of intracellular organelles are not restricted 
to the TGN. These data suggest that integral membrane 
proteins are being internalised appropriately in the pres- 
ence of chloroquine of Bafilomycin A,, but being held up 
in an early endocytic compartment prior to the point on 
the endocytic pathway where internalised membrane 
proteins are routed to their post-internalisation destina- 
tion. TGN38/41 and M-6-PR co-accumulate in ‘dough- 
nut-like’ structures which precede the point on the endo- 
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cytic pathway at which they are segregated to their later 
intracellular destinations. Lgpl20 does not co-accumu- 
late with TGN38/41 and M-6-PR since it is routed di- 
rectly to lysosomal membranes from the TGN and does 
not traffic through that part of the endocytic pathway 
where TGN38/41 and M-6-PR co-accumulate. 
3.3. Location of the chloroquinelBafilomycin A, induced 
block on endocytosis 
We and others have previously shown that BFA in- 
duces a collapse of the TGN upon the microtubule or- 
ganising centre (MTOC) [4,9], and that pre-treatment of 
cells with the microtubule depolymerising drug Noco- 
dazole induces fragmentation of the TGN [4]. If chloro- 
quine and Bafilomycin Ai are holding up intemalised 
TGN38/41 in an early endocytic compartment, then (i) 
one would not expect nocodazole to have any effect upon 
the intracellular distribution of TGN38/41 in chloro- 
quine or Bafilomycin A, treated cells since the formation 
of early endosomes does not require the presence of in- 
tact microtubules [29], but (ii) one would expect BFA to 
have an effect upon the intracellular distribution of 
TGN38/41 in chloroquine or Bafilomycin A, treated 
cells since this drug has been reported to lead to a fusion 
of early endosomes with the TGN [30]. These predictions 
were tested by incubating NRK cells in the presence of 
chloroquine, prior to incubation in either nocodazole or 
BFA, then processing for immunofluorescence analysis 
using a monoclonal antibody to TGN38/41. There is no 
observable effect of either nocodazole or BFA on cells 
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which have been pre-treated with chloroquine (Fig. 
4A,B), i.e. the chloroquine effect is observed (compare 
with e.g. Fig. 2C). Since treatment of cells with either 
BFA or nocodazole leads to a redistribution of TGN38/ 
41, one might expect that pre-treatment with either of 
these drugs would protect cells from the effects of chloro- 
quine. In order to determine whether this was the case, 
NRK cells were incubated in the presence of either BFA 
or nocodazole prior to incubation in chloroquine 
then processed for immunofluorescence analysis using a 
monoclonal antibody to TGN38/41. The BFA redistri- 
bution pattern is observed in the case of BFA pre- 
treatment (Fig. 4C), and the nocodazole fragmentation 
pattern is observed in the case of nocodazole pre-treat- 
ment (Fig. 4D). 
These data suggest that after BFA or nocodazole 
treatment the compartment which contains the majority 
of TGN38/41 is no longer susceptible to the effects of 
chloroquine and that chloroquine pre-treatment ablates 
the effects of BFA and nocodazole. This is consistent 
with the hypothesis that TGN38/41 accumulates in early 
endosomes in response to chloroquine or Bafdomycin Ai 
treatment of cells and also implies that BFA treatment 
inhibits the transport of TGN38/41 to the cell surface; if 
it did not, the intracellular distribution of TGN38/41 
would continue to be susceptible to the effects of chloro- 
quine. These data are consistent with our earlier observa- 
tion that BFA treatment reduces the level of TGN38/41 
expressed at the cell surface [lo] and the observation of 
others that Bafrlomycin A, induced inactivation of vacu- 
Fig. 4. Location of the chloroquine/Bafilomycin A, induced block on endocytosis. NRK cells were either (i) incubated in the presence of 40 ,uM 
chloroquine for one hour then for a further two hours in 5 @ml BFA (A) or 2O&ml nocodazole (B) in the continued presence. of 4OpM chloroquine, 
or (ii) incubated in the presence of 5 &ml BFA or 20 &ml nocodazole for one hour then for a further two hours in 40 ,KM chloroquine in the 
continued presence of either BFA (C) or nocodazole (D) at 37°C prior to methanol fixation and processing for imrmmofluorescence analysis using 
a polyclonal antibody to TGN38/41 detected with a TRITC-labelled goat anti-rabbit IgG. 
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olar ATPase blocks the formation of endocytic carrier 
vesicles from early endosomes [31]. However they are not 
in accord with the suggestion that BFA induces a fusion 
of early endosomes with the TGN [30], since BFA treat- 
ment has no effect on the distribution of TGN38/41 in 
chloroquine treated cells (Fig. 4B). Thus the endocytic 
compartment which is seen to fuse with the TGN in BFA 
treated cells [30] must be a post early endosome struc- 
ture, possibly endocytic carrier vesicles. An alternative 
explanation is that the effect of chloroquine upon early 
endosomes is such that BFA can no longer exert an effect 
on their membranes and thus cannot induce their fusion 
with the TGN. 
Thus, elevating the lumenal pH of intracellular organ- 
elles leads to a block on the endocytic pathway at the 
point of early endosomes, this in turn affects the intracel- 
lular distribution of TGN38/41 as it does the recyling of 
the transferrin receptor [32] and the ‘Qr-543 mutant of 
HA [17]. The total pool of TGN38/41 appears to cycle 
from the TGN via the cell surface and back to the TGN 
within one hour, since the majority of TGN38/41 ap- 
pears to be in chloroquine induced ‘doughnut’ structures 
within one hour of incubation in the drug. 
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